- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Gilead Sciences Inc. (GILD)
Index:
- Change Today: $-3.67
- 52 Week High: $128.07
- 52 Week Low: $89.14
- Currency: US Dollars
- Shares Issued: 1,246.00m
- Volume: 3,369,058
- Market Cap: $146,947m
- RiskGrade: 120
Trade now with Barclays Stockbrokers
Update - 
Latest ShareCast News
GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill
By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
GILD ShareCast News
GILD Newspaper Links
GILD Tips & Analysis
GILD News Wires
GILD Market Data
| Currency | US Dollars |
| Share Price | $ 117.94 |
| Change Today | $ -3.67 |
| % Change | -3.01 % |
| 52 Week High | $128.07 |
| 52 Week Low | $89.14 |
| Volume | 3,369,058 |
| Shares Issued | 1,246.00m |
| Market Cap | $146,947m |
| RiskGrade | 120 |
What The Brokers Say
| Strong Buy | 9 |
| Buy | 13 |
| Neutral | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN